EMBioSys is ructured around development of a platform of non-pharmacological therapeutics designed to utilize low level induced electric fields (iEF Therapy) for treatment of breast cancer. The firms iEF Therapy is indicated by management as unique unique: the approach of the firm is to deploy it in the form of home-use, electrode-free, wearable garments. Management's efficacy data has proven that iEF Therapy (1) hinders metastasis, (2) reduces the volume and weight of the primary tumor, and (3) improves the efficacy of chemotherapy - while increasing the host immune response, while selectively targeting only cancer cells.
